Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v6-EN
Language French English
Date Updated 2021-01-14 2021-01-07
Drug Identification Number 02285967 02285967
Brand name TEVA-ACYCLOVIR TEVA-ACYCLOVIR
Common or Proper name TEVA-ACYCLOVIR 400MG TABLETS TEVA-ACYCLOVIR 400MG TABLETS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ACYCLOVIR ACYCLOVIR
Strength(s) 400MG 400MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-20 2020-08-20
Estimated end date Unknown 2021-01-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments